Transcriptomics

Dataset Information

The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth


ABSTRACT: The overall goal of this study was to characterize the activity and mechanism(s) of action of the pan-Jumonji domain histone demethylase small molecule inhibitor JIB-04 in the pediatric bone and soft tissue cancer Ewing Sarcoma.

ORGANISM(S): Homo sapiens

PROVIDER: GSE119832 | GEO | 2019/01/03

REPOSITORIES: GEO